Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193125-26-006427
Filing Date
2026-01-07
Accepted
2026-01-07 16:40:03
Documents
1
Period of Report
2026-01-05

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4018
  Complete submission text file 0001193125-26-006427.txt   5586
Mailing Address 300 TRI STATE INTERNATIONAL SUITE 272 LINCOLNSHIRE IL 60069
Business Address
ZACCARDELLI DAVID (Reporting) CIK: 0001627642 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39871 | Film No.: 26516220

Mailing Address 777 W 41ST ST SUITE 401 MIAMI BEACH FL 33140
Business Address 777 W 41ST ST SUITE 401 MIAMI BEACH FL 33140 305-845-2813
SAB Biotherapeutics, Inc. (Issuer) CIK: 0001833214 (see all company filings)

EIN.: 853899721 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)